Büll C - Search Results

1

Sialic Acid Mimetics to Target the Sialic Acid-Siglec Axis.

Büll C, Heise T, Adema GJ, Boltje TJ. Büll C, et al. Trends Biochem Sci. 2016 Jun;41(6):519-531. doi: 10.1016/j.tibs.2016.03.007. Epub 2016 Apr 13. Trends Biochem Sci. 2016. PMID: 27085506 Review.

2

Targeting aberrant sialylation in cancer cells using a fluorinated sialic acid analog impairs adhesion, migration, and in vivo tumor growth.

Büll C, Boltje TJ, Wassink M, de Graaf AM, van Delft FL, den Brok MH, Adema GJ. Büll C, et al. Mol Cancer Ther. 2013 Oct;12(10):1935-46. doi: 10.1158/1535-7163.MCT-13-0279. Epub 2013 Aug 23. Mol Cancer Ther. 2013. PMID: 23974695

3

Sialic acids sweeten a tumor's life.

Büll C, Stoel MA, den Brok MH, Adema GJ. Büll C, et al. Cancer Res. 2014 Jun 15;74(12):3199-204. doi: 10.1158/0008-5472.CAN-14-0728. Epub 2014 May 15. Cancer Res. 2014. PMID: 24830719 Review.

4

Sweet escape: sialic acids in tumor immune evasion.

Büll C, den Brok MH, Adema GJ. Büll C, et al. Biochim Biophys Acta. 2014 Aug;1846(1):238-46. doi: 10.1016/j.bbcan.2014.07.005. Epub 2014 Jul 12. Biochim Biophys Acta. 2014. PMID: 25026312 Review.

5

Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal α-dystroglycan O-mannosylation, independent from sialic acid.

Riemersma M, Sandrock J, Boltje TJ, Büll C, Heise T, Ashikov A, Adema GJ, van Bokhoven H, Lefeber DJ. Riemersma M, et al. Among authors: bull c. Hum Mol Genet. 2015 Apr 15;24(8):2241-6. doi: 10.1093/hmg/ddu742. Epub 2014 Dec 30. Hum Mol Genet. 2015. PMID: 25552652

6

Targeted delivery of a sialic acid-blocking glycomimetic to cancer cells inhibits metastatic spread.

Büll C, Boltje TJ, van Dinther EA, Peters T, de Graaf AM, Leusen JH, Kreutz M, Figdor CG, den Brok MH, Adema GJ. Büll C, et al. ACS Nano. 2015 Jan 27;9(1):733-45. doi: 10.1021/nn5061964. Epub 2015 Jan 14. ACS Nano. 2015. PMID: 25575241

7

Sialic Acid Glycoengineering Using an Unnatural Sialic Acid for the Detection of Sialoglycan Biosynthesis Defects and On-Cell Synthesis of Siglec Ligands.

Büll C, Heise T, Beurskens DM, Riemersma M, Ashikov A, Rutjes FP, van Kuppevelt TH, Lefeber DJ, den Brok MH, Adema GJ, Boltje TJ. Büll C, et al. ACS Chem Biol. 2015 Oct 16;10(10):2353-63. doi: 10.1021/acschembio.5b00501. Epub 2015 Aug 10. ACS Chem Biol. 2015. PMID: 26258433

8

The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells.

Gram AM, Oosenbrug T, Lindenbergh MF, Büll C, Comvalius A, Dickson KJ, Wiegant J, Vrolijk H, Lebbink RJ, Wolterbeek R, Adema GJ, Griffioen M, Heemskerk MH, Tscharke DC, Hutt-Fletcher LM, Wiertz EJ, Hoeben RC, Ressing ME. Gram AM, et al. Among authors: bull c. PLoS Pathog. 2016 Apr 14;12(4):e1005550. doi: 10.1371/journal.ppat.1005550. eCollection 2016 Apr. PLoS Pathog. 2016. PMID: 27077376 Free PMC article.

9

Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma.

Kroesen M, Büll C, Gielen PR, Brok IC, Armandari I, Wassink M, Looman MW, Boon L, den Brok MH, Hoogerbrugge PM, Adema GJ. Kroesen M, et al. Among authors: bull c. Oncoimmunology. 2016 Mar 28;5(6):e1164919. doi: 10.1080/2162402X.2016.1164919. eCollection 2016 Jun. Oncoimmunology. 2016. PMID: 27471639 Free PMC article.

10

Saponin-based adjuvants induce cross-presentation in dendritic cells by intracellular lipid body formation.

den Brok MH, Büll C, Wassink M, de Graaf AM, Wagenaars JA, Minderman M, Thakur M, Amigorena S, Rijke EO, Schrier CC, Adema GJ. den Brok MH, et al. Among authors: bull c. Nat Commun. 2016 Nov 7;7:13324. doi: 10.1038/ncomms13324. Nat Commun. 2016. PMID: 27819292 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

682 results

Search Page

Filters